8-Chloro-2H-benzo[b][1,4]oxazin-3(4H)-one

Catalog No.: 
ACHODT715
CAS No.: 
57245-31-5
Molecular Formula: 
C8H6ClNO2
Molecular Weight: 
183.59
8-Chloro-2H-benzo[b][1,4]oxazin-3(4H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$119.00InquiryInquiry
100mg95%$167.00InquiryInquiry
250mg95%$231.00InquiryInquiry
1g95%$552.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Chloro-2H-benzo[b][1,4]oxazin-3(4H)-one
IUPAC Name8-chloro-2H-benzo[b][1,4]oxazin-3(4H)-one
MDL No.MFCD08111618
Molecular FormulaC8H6ClNO2
Molecular Weight183.59
SMILESO=C1COC2C(=CC=CC=2Cl)N1
InChI KeyMRMNWSPHQCJZBC-UHFFFAOYSA-N
Synonym8-CHLORO-2H-1,4-BENZOXAZIN-3(4H)-ONE;8-CHLORO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE;TIMTEC-BB SBB014314;8-chloro-3,4-dihydro-2H-1,4-benzoxazin-3-one;2H-1,4-Benzoxazin-3(4H)-one, 8-chloro-;8-Chloro-4H-benzo[1,4]oxazin-3-one
CAS No.57245-31-5
PubChem CID8027209

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHODT715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHODT715 route product structure diagram
    ACHODT71557245-31-5
Inquiry

2. ACHODT715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHODT715 route product structure diagram
    ACHODT71557245-31-5
Inquiry

3. ACHODT715 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHODT715 route product structure diagram
    ACHODT71557245-31-5
Inquiry

Comments (0)